Bernstein Reaffirms Their Buy Rating on Waters (WAT)

In a report released today, Eve Burstein from Bernstein maintained a Buy rating on Waters, with a price target of $450.00.

Burstein covers the Healthcare sector, focusing on stocks such as Waters, Agilent, and Illumina. According to TipRanks, Burstein has an average return of 25.0% and a 78.18% success rate on recommended stocks.

In addition to Bernstein, Waters also received a Buy from TD Cowen’s Daniel Brennan in a report issued on October 13. However, on October 9, Bank of America Securities maintained a Hold rating on Waters (NYSE: WAT).

Based on Waters’ latest earnings release for the quarter ending July 4, the company reported a quarterly revenue of $1.65 billion and a GAAP net loss of $136 million. In comparison, last year the company earned a revenue of $771.33 million and had a net profit of $147.11 million

Based on the recent corporate insider activity of 44 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of WAT in relation to earlier this year. Most recently, in August 2026, Christopher Kuebler, a Director at WAT sold 3,626.00 shares for a total of $1,442,930.44.